Longitudinal Early-onset Alzheimer's Disease Study Protocol

Key facts

Sponsor

Indiana University

Principal Investigator

Liana Apostolova, MD

Indiana University

Intervention

Flortaucipir(drug)

Enrollment

850 enrolled

Eligibility

40-64 years · All sexes

Timeline

2018 – 2026

Study locations (23)

• Banner Sun Health Research Institute, Sun City, Arizona, United States
• University of California, Los Angeles, Los Angeles, California, United States
• Stanford University, Palo Alto, California, United States
• University of California, San Francisco, San Francisco, California, United States
• Georgetown University, Washington D.C., District of Columbia, United States
• Mayo Clinic, Jacksonville, Jacksonville, Florida, United States
• Wien Center, Miami Beach, Florida, United States
• Emory University, Atlanta, Georgia, United States
• Northwestern University, Chicago, Illinois, United States
• Indiana University, Indianapolis, Indiana, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Massachusetts General Hospital, Boston, Massachusetts, United States
• Mayo Clinic, Rochester, Rochester, Minnesota, United States
• Washington University, St. Louis, St Louis, Missouri, United States
• Columbia University, New York, New York, United States
• +8 more locations on ClinicalTrials.gov

Collaborators

Alzheimer's Therapeutic Research Institute · National Institute on Aging (NIA) · Alzheimer's Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNANCT07250113
  WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT
  Northwell Health
• RECRUITINGNCT07457138
  Lombard Cohort of Brain Health Services
  University of Milano Bicocca
• RECRUITINGNANCT07286448
  Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment
  Giovanna Zamboni
• ACTIVE NOT RECRUITINGNANCT07479914
  Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
  University of Milano Bicocca
• RECRUITINGNANCT07212504
  Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems
  Rotman Research Institute at Baycrest
• ENROLLING BY INVITATIONNANCT07168824
  An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition
  Chi-Chang Huang
• ACTIVE NOT RECRUITINGNANCT07350226
  Electro-acupuncture for SCD With Depression
  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
• RECRUITINGNCT07402161
  The Signature of Alzheimer's Disease in Subjective Cognitive Decline
  IRCCS Policlinico S. Donato

See all trials for NON RARE IN EUROPE: Alzheimer disease →